Articles with public access mandates - Hans-Georg RammenseeLearn more
Not available anywhere: 25
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
S Walter, T Weinschenk, A Stenzl, R Zdrojowy, A Pluzanska, C Szczylik, ...
Nature medicine 18 (8), 1254-1261, 2012
Mandates: German Research Foundation
Actively personalized vaccination trial for newly diagnosed glioblastoma
N Hilf, S Kuttruff-Coqui, K Frenzel, V Bukur, S Stevanović, ...
Nature 565 (7738), 240-245, 2019
Mandates: Cancer Research UK, UK Medical Research Council
Inhibitors of indoleamine-2, 3-dioxygenase for cancer therapy: can we see the wood for the trees?
S Löb, A Königsrainer, HG Rammensee, G Opelz, P Terness
Nature Reviews Cancer 9 (6), 445-452, 2009
Mandates: US National Institutes of Health
Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy
C Berlin, DJ Kowalewski, H Schuster, N Mirza, S Walz, M Handel, ...
Leukemia 29 (3), 647-659, 2015
Mandates: German Research Foundation
The mouse dendritic cell marker CD11c is down-regulated upon cell activation through Toll-like receptor triggering
H Singh-Jasuja, A Thiolat, M Ribon, MC Boissier, N Bessis, ...
Immunobiology 218 (1), 28-39, 2013
Mandates: German Research Foundation, National Institute of Health and Medical …
Immunogenic stress and death of cancer cells: contribution of antigenicity vs adjuvanticity to immunosurveillance
N Bloy, P Garcia, CM Laumont, JM Pitt, A Sistigu, G Stoll, T Yamazaki, ...
Immunological reviews 280 (1), 165-174, 2017
Mandates: European Commission, Swiss Cancer League, Government of Italy, Leducq …
Promiscuous survivin peptide induces robust CD4+ T‐cell responses in the majority of vaccinated cancer patients
M Widenmeyer, H Griesemann, S Stevanović, S Feyerabend, R Klein, ...
International journal of cancer 131 (1), 140-149, 2012
Mandates: German Research Foundation
An impedance-based cytotoxicity assay for real-time and label-free assessment of T-cell-mediated killing of adherent cells
JK Peper, H Schuster, MW Löffler, B Schmid-Horch, HG Rammensee, ...
Journal of immunological methods 405, 192-198, 2014
Mandates: German Research Foundation
Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy
MC Neidert, O Schoor, C Trautwein, N Trautwein, L Christ, A Melms, ...
Journal of neuro-oncology 111, 285-294, 2013
Mandates: German Research Foundation
Identification and Characterization of T-Cell Epitopes Deduced from RGS5, a Novel Broadly Expressed Tumor Antigen
CN Boß, F Grünebach, K Brauer, M Häntschel, V Mirakaj, ...
Clinical cancer research 13 (11), 3347-3355, 2007
Mandates: German Research Foundation
TLR2/TLR4-independent neutrophil activation and recruitment upon endocytosis of nucleosomes reveals a new pathway of innate immunity in systemic lupus erythematosus
VM Rönnefarth, AIM Erbacher, T Lamkemeyer, J Madlung, A Nordheim, ...
The Journal of Immunology 177 (11), 7740-7749, 2006
Mandates: German Research Foundation
Identification of natural MHC class II presented phosphopeptides and tumor-derived MHC class I phospholigands
VS Meyer, O Drews, M Günder, J Hennenlotter, HG Rammensee, ...
Journal of proteome research 8 (7), 3666-3674, 2009
Mandates: German Research Foundation
A bispecific single-chain antibody that mediates target cell-restricted, supra-agonistic CD28 stimulation and killing of lymphoma cells
T Otz, L Grosse-Hovest, M Hofmann, HG Rammensee, G Jung
Leukemia 23 (1), 71-77, 2009
Mandates: German Research Foundation
Advances in PET imaging of cancer
J Schwenck, D Sonanini, JM Cotton, HG Rammensee, C la Fougère, ...
Nature Reviews Cancer 23 (7), 474-490, 2023
Mandates: German Research Foundation
MHCquant: automated and reproducible data analysis for immunopeptidomics
L Bichmann, A Nelde, M Ghosh, L Heumos, C Mohr, A Peltzer, ...
Journal of proteome research 18 (11), 3876-3884, 2019
Mandates: German Research Foundation, Federal Ministry of Education and Research, Germany
High-throughput peptide-MHC complex generation and kinetic screenings of TCRs with peptide-receptive HLA-A* 02: 01 molecules
A Moritz, R Anjanappa, C Wagner, S Bunk, M Hofmann, G Pszolla, ...
Science Immunology 4 (37), eaav0860, 2019
Mandates: German Research Foundation, European Commission
Long-term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling
VS Meyer, W Kastenmuller, G Gasteiger, M Franz-Wachtel, ...
The Journal of Immunology 181 (9), 6371-6383, 2008
Mandates: German Research Foundation
Results of a phase 1/2 study in metastatic renal cell carcinoma patients treated with a patient-specific adjuvant multi-peptide vaccine after resection of metastases
S Rausch, C Gouttefangeas, J Hennenlotter, K Laske, K Walter, ...
European Urology Focus 5 (4), 604-607, 2019
Mandates: German Research Foundation
Identification of immunogenic epitopes by MS/MS
M Di Marco, JK Peper, HG Rammensee
The Cancer Journal 23 (2), 102-107, 2017
Mandates: German Research Foundation, European Commission
Autoreactive napsin A–specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade
F Berner, D Bomze, C Lichtensteiger, V Walter, R Niederer, O Hasan Ali, ...
Science immunology 7 (75), eabn9644, 2022
Mandates: Swiss National Science Foundation, Swiss Cancer League
Publication and funding information is determined automatically by a computer program